March 23, 2021
Takeda Pharmaceutical has filed an application for an additional OD tablet formulation of the acid reducer Takecab Tablets 10 mg/20 mg (vonoprazan) in Japan, the company and its copromotion partner Otsuka Pharmaceutical said on March 22. The OD formulation is...read more